CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
MDx has developed PrePsia™, a blood test that identifies pregnant women at risk of preterm preeclampsia up to five months early. This allows for timely interventions that can significantly reduce the incidence of this serious condition.
Preeclampsia is responsible for the deaths of more than 70,000 mothers and half a million babies each year.
Identifying those mothers at risk of preeclampsia is difficult.
The current gold standard in prenatal care does not detect the disease early enough to change the course of the disease. MDx has developed PrePsia™, a simple blood test which identifies an expectant mother’s risk of preterm preeclampsia, up to 5 months before most women will display clinical symptoms.
Clinicians can now use th…
METABOLOMIC DIAGNOSTICS LIMITED
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
